Can I Take Reishi Mushroom With Synthroid (Levothyroxine)?

At a glance

  • Primary concern / pharmacodynamic interaction, possible immune and anticoagulant effects
  • Absorption risk / low direct evidence, but separation by 4 hours is the standard precaution
  • Who is most affected / women with autoimmune thyroid disease (Hashimoto's), those on anticoagulants, pregnant women
  • Pregnancy status / reishi mushroom should be avoided in pregnancy; levothyroxine is safe and necessary
  • Life stage note / perimenopause amplifies thyroid symptom overlap; interaction monitoring matters more at this stage
  • Evidence quality / mostly preclinical and small human studies; no large RCT in women specifically
  • Monitoring / TSH recheck 6-8 weeks after adding any new supplement to your regimen
  • Dose of levothyroxine affected / any dose; there is no safe threshold below which monitoring is unnecessary

What Is Reishi Mushroom and Why Do Women Take It?

Reishi (Ganoderma lucidum) is a woody fungus used in East Asian herbal medicine for over 2,000 years. Among women, it is most often taken for immune support, stress reduction, sleep quality, and perimenopausal fatigue. Supplement sales have grown sharply since 2020, and reishi now appears in many "women's wellness" blends alongside ashwagandha and maca.

The active compounds include polysaccharides (beta-glucans) and triterpenes (ganoderic acids), which drive most of its studied biological effects. Those effects matter when you are also taking a narrow-therapeutic-index drug like levothyroxine.

Why Thyroid Patients Are Drawn to Reishi

Fatigue, brain fog, hair thinning, and immune vulnerability are common complaints in women with hypothyroidism, even when TSH is nominally controlled. Reishi is marketed as addressing all four. That overlap in target symptoms is exactly why so many women on Synthroid end up asking about it.

How Common Is Hypothyroidism in Women?

Hypothyroidism affects approximately 5 percent of the US population and is five to eight times more common in women than men. Hashimoto's thyroiditis, an autoimmune condition, accounts for the majority of cases in women of reproductive age and is the leading reason women are prescribed levothyroxine long-term.


How Levothyroxine Works and Why Interactions Matter So Much

Levothyroxine is a synthetic form of thyroxine (T4). Your body converts it to the active hormone triiodothyronine (T3), which regulates metabolism, body temperature, heart rate, and reproductive function. The therapeutic window for levothyroxine is narrow: even small shifts in absorption or clearance can push TSH out of range and bring back symptoms you worked hard to eliminate.

Pharmacokinetics: What Makes Levothyroxine Vulnerable

Levothyroxine is absorbed primarily in the small intestine. Bioavailability ranges from 40 to 80 percent depending on the formulation, food, stomach acid, and co-administered substances. Anything that alters gastric pH, binds to the drug in the gut, or changes thyroid hormone metabolism can shift your effective dose.

Classic absorption blockers include calcium carbonate, iron sulfate, antacids, and certain dietary fibers. Reishi does not appear to bind levothyroxine directly, but that is not the only mechanism worth watching.

The Narrow Therapeutic Index Problem

A TSH shift from 1.5 to 4.8 mIU/L can mean the difference between feeling well and experiencing crushing fatigue, constipation, and hair loss, even though both values are technically within the lab's reference range. This is why any supplement that modulates immune function, liver enzyme activity, or gut transit time deserves scrutiny when you are a levothyroxine user.


The Specific Interaction Concerns With Reishi Mushroom

There are two distinct mechanisms through which reishi could affect your Synthroid therapy. One is pharmacodynamic (affecting what the drug does in your body). The other involves thyroid biology directly.

Concern 1: Immunomodulation and Autoimmune Thyroid Disease

Reishi's beta-glucans stimulate macrophage activity, natural killer cells, and dendritic cell maturation. A 2006 study published in the Journal of Ethnopharmacology found that Ganoderma lucidum polysaccharides significantly upregulated TNF-alpha, IL-1, and IL-6 production in human mononuclear cells.

For a woman with Hashimoto's thyroiditis, whose disease is already driven by immune dysregulation, stimulating pro-inflammatory cytokines is not without risk. Theoretically, increased immune activation could worsen thyroid gland inflammation and accelerate destruction of remaining thyroid tissue, requiring upward dose adjustments. This has not been confirmed in a clinical trial, and the effect size is unknown. The concern is biologically plausible, not proven.

WomanRx clinical framework: Women with Hashimoto's fall into a higher-concern category for reishi than women with hypothyroidism from other causes (such as post-thyroidectomy or radioiodine ablation), because the immune-stimulating action of reishi is directly relevant to their underlying disease mechanism. If you have Hashimoto's, the risk-benefit calculus is different from someone taking levothyroxine after surgery.

Concern 2: Anticoagulant Potentiation

Reishi triterpenes inhibit platelet aggregation. A 2004 in vitro study in Chemistry and Biology showed ganoderic acid S and T inhibited platelet aggregation by up to 46 percent. Levothyroxine itself enhances the effect of anticoagulants like warfarin by increasing the catabolism of clotting factors. If you are on both warfarin and Synthroid, adding reishi creates a three-way potentiation scenario that can raise bleeding risk meaningfully.

Even without warfarin in the picture, women who take NSAIDs regularly, have heavy menstrual bleeding, are post-surgical, or are approaching menopause (when cardiovascular risk rises) should factor this in.

Concern 3: Possible Direct Thyroid Activity

Several animal studies have examined whether Ganoderma species have direct effects on thyroid hormone levels. A 2012 study in rodents found that high-dose Ganoderma lucidum extract lowered serum T4 and T3 concentrations, which would worsen hypothyroidism and require a higher levothyroxine dose to compensate. This finding has not been replicated in a human trial. Rodent data cannot be directly applied to women, and the doses used were far above typical supplement amounts. Still, the directional signal is worth knowing.

Concern 4: Liver Enzyme Modulation

Ganoderic acids are metabolized in the liver and may modulate cytochrome P450 enzymes, particularly CYP1A2 and CYP3A4. Thyroid hormone itself is partially metabolized via CYP pathways, and disruption of these enzymes could theoretically alter T3/T4 conversion or clearance. The evidence here is largely preclinical. No human pharmacokinetic study has measured the effect of standard reishi supplement doses on levothyroxine metabolism directly.


What the Evidence Actually Shows (and Where It Falls Short)

Honestly, the clinical evidence on this specific combination is thin. There is no published randomized controlled trial examining TSH, T4, or T3 outcomes in women taking reishi alongside levothyroxine. What exists is:

  • Preclinical pharmacology of reishi's immune and anticoagulant mechanisms
  • Rodent data on thyroid hormone suppression
  • Human trials on reishi for other endpoints (cancer-related fatigue, immune markers) that were not designed to assess thyroid outcomes
  • Case reports and interaction database flags from Natural Medicines Comprehensive Database (which rates the reishi-levothyroxine combination as having "insufficient evidence" for safety with a note on potential immunomodulatory concern)

Women have been historically underrepresented in supplement-drug interaction trials, and thyroid-focused interaction studies are no exception. The data that does exist is largely extrapolated from male subjects or mixed-sex cohorts without sex-stratified analysis. This is an honest evidence gap, not a reason to panic, but it is a reason to be more conservative rather than less.


Does Reishi Affect TSH or Thyroid Hormone Levels Directly?

The short answer: possibly, but not confirmed in humans at supplement doses. The rodent study mentioned above used doses equivalent to several grams of pure extract daily, far above the 500 mg to 1,500 mg per day range typically found in commercial capsules. You should not assume your 500 mg daily capsule will suppress your T4, but you also should not assume it is completely inert.

Getting a TSH check 6 to 8 weeks after starting reishi (or stopping it) is the most practical way to detect any clinically meaningful change in your thyroid status.


Life Stage Considerations for Women on Levothyroxine

Reproductive Years and Trying to Conceive

Women planning pregnancy need their TSH optimized before conception. ACOG and the American Thyroid Association recommend a preconception TSH below 2.5 mIU/L for women with known hypothyroidism. Adding an unproven supplement that may shift thyroid hormone metabolism at this stage is a real risk. Avoid reishi during preconception preparation unless your endocrinologist has reviewed your case specifically.

Perimenopause

This is where the interaction concern becomes particularly relevant in practice. Perimenopausal women experience symptom overlap between estrogen decline and undertreated hypothyroidism: fatigue, cognitive changes, sleep disruption, mood shifts, weight changes. Many women in their mid-40s to mid-50s reach for adaptogens and immune supplements because standard care has not fully addressed their symptoms. TSH reference ranges may need adjustment in perimenopause as hormone flux affects thyroid binding globulin. Adding reishi to an already shifting hormonal backdrop means you need more frequent monitoring, not less.

Postmenopause

Postmenopausal women are at higher risk for osteoporosis if levothyroxine is over-replaced (suppressed TSH accelerates bone loss). They are also at higher cardiovascular risk. Because reishi may affect platelet function, postmenopausal women who have cardiovascular risk factors or take anticoagulants should discuss the combination with their cardiologist or internist before proceeding.


Pregnancy and Lactation Safety

Levothyroxine in pregnancy: Levothyroxine is safe and necessary in pregnancy. Untreated or undertreated hypothyroidism is associated with increased risk of miscarriage, preterm birth, and impaired fetal neurodevelopment. Levothyroxine dose requirements increase by approximately 25 to 50 percent starting in the first trimester. ACOG Practice Bulletin 223 (2020) recommends checking TSH every 4 weeks in the first half of pregnancy for women on levothyroxine.

Reishi mushroom in pregnancy: Reishi should not be used during pregnancy. Animal reproduction studies have shown adverse effects with high-dose Ganoderma extracts, and no adequate human safety data exists. Given its platelet-inhibiting and immunomodulatory properties, the risk-benefit calculation is unfavorable. The Natural Medicines Comprehensive Database classifies reishi as "Possibly Unsafe" in pregnancy.

Lactation: Levothyroxine transfers into breast milk in small amounts, but the American Academy of Pediatrics considers it compatible with breastfeeding because the infant's exposure is physiologically negligible. Reishi in lactation has no adequate safety data. Until human lactation studies are conducted, avoiding reishi while breastfeeding is the more cautious path.

Contraception note: Levothyroxine is not a teratogen and does not require contraception. Reishi is not known to reduce contraceptive efficacy, but if you are using hormonal contraception, be aware that estrogen-containing pills increase thyroid binding globulin, which raises total T4 and may change your levothyroxine dose requirement. This is separate from the reishi question but relevant to the full picture.


Who This Combination Is and Is Not Appropriate For

Lower Concern (Discuss With Your Doctor, Monitor TSH)

  • Women with hypothyroidism from post-thyroidectomy or radioiodine ablation (no autoimmune component)
  • Women who are not pregnant, not planning pregnancy, and not breastfeeding
  • Women on no anticoagulants and with no bleeding disorders
  • Women whose TSH has been stable for at least 6 months

Higher Concern (Avoid or Proceed Only With Specialist Input)

  • Women with Hashimoto's thyroiditis (autoimmune disease; immune stimulation is directly relevant)
  • Women who are pregnant, trying to conceive, or breastfeeding
  • Women taking warfarin, heparin, or other anticoagulants
  • Women on NSAIDs regularly or with heavy menstrual periods
  • Women with TSH that is currently unstable or recently adjusted
  • Women in perimenopause with rapidly shifting thyroid-binding globulin levels

How to Take Reishi If Your Doctor Clears It

If your clinician reviews your situation and decides the risk is acceptable, timing still matters. Standard supplement-separation principles apply:

  1. Take levothyroxine first thing in the morning, 30 to 60 minutes before food or other supplements, as directed.
  2. Wait at least four hours before taking reishi or any other supplement.
  3. Take reishi consistently. Irregular use makes it harder to spot TSH drift because your exposure is variable.
  4. Schedule a TSH check at 6 to 8 weeks after starting. If TSH has shifted more than 0.5 mIU/L from your personal baseline, report it to your prescriber before the scheduled visit.
  5. Tell every clinician on your care team, including your pharmacist, that you are taking reishi.

The four-hour separation window is a precautionary standard borrowed from the well-characterized absorption interactions (calcium, iron, fiber) rather than from direct reishi-levothyroxine PK data. It is a practical minimum, not a guarantee.


What to Tell Your Doctor

Bring these specific questions to your next visit:

  • "My current TSH is [X]. Is that stable enough to trial a new supplement?"
  • "I have [Hashimoto's / ablated thyroid / stable hypothyroidism]. Does my specific situation change the risk?"
  • "I take [warfarin / aspirin / other anticoagulant]. Does that change whether reishi is safe?"
  • "Can we schedule a TSH recheck 6 weeks after I start, to see if anything shifts?"

You are not asking permission. You are giving your prescriber the information they need to help you make a safe decision.


Practical Monitoring Table

| Timing | Action | |---|---| | Before starting reishi | Get a baseline TSH and free T4 | | 6-8 weeks after starting | Repeat TSH and free T4 | | Any new symptom (fatigue, palpitations, hair loss) | Contact prescriber, do not wait for scheduled lab | | Stopping reishi | Recheck TSH at 6-8 weeks; dose may need to adjust back | | Starting or stopping hormonal contraception | Recheck TSH at 6-8 weeks regardless of reishi status |


What About Other Mushroom Supplements?

Women often take mushroom blends that combine reishi with lion's mane, chaga, turkey tail, or cordyceps. Chaga contains significant amounts of oxalate and has its own anticoagulant properties. Lion's mane has been shown to stimulate nerve growth factor but has limited interaction data with thyroid medications. If you are taking a blend rather than single-ingredient reishi, the interaction picture is more complex and deserves individual pharmacist review of the full ingredient list.


Frequently asked questions

Can I take reishi mushroom while on Synthroid?
You may be able to, but it requires a conversation with your prescriber first. Reishi has immunomodulatory and platelet-inhibiting properties that are relevant to women on levothyroxine, especially those with Hashimoto's thyroiditis or on blood thinners. If cleared, take reishi at least four hours after your morning Synthroid dose and recheck your TSH at six to eight weeks.
Does reishi mushroom interact with Synthroid?
There is no confirmed pharmacokinetic interaction where reishi directly blocks levothyroxine absorption. The concern is pharmacodynamic: reishi's immune-stimulating and anticoagulant properties may indirectly affect how well your thyroid treatment works, particularly in women with autoimmune thyroid disease. Animal data also suggests high-dose reishi extract may suppress thyroid hormone levels, but this has not been replicated in human trials.
Is reishi mushroom safe with Synthroid?
Safety depends on your specific situation. Women with Hashimoto's, those who are pregnant or breastfeeding, or those on anticoagulants face a higher-concern profile. Women with stable hypothyroidism from non-autoimmune causes and no other complicating factors have a lower-concern profile. No supplement combination is universally safe or universally unsafe; the answer is specific to your health history.
Can reishi mushroom raise or lower TSH?
Animal studies found that high-dose Ganoderma lucidum extract lowered T4 and T3 in rodents, which would raise TSH in a feedback response. No human RCT has confirmed this at typical supplement doses. Monitoring your TSH before and six to eight weeks after starting reishi is the most reliable way to know whether your levels have shifted.
Does reishi affect thyroid antibodies in Hashimoto's?
No published clinical trial has measured the effect of reishi on TPO antibodies or thyroglobulin antibodies in Hashimoto's patients. Reishi's known ability to stimulate pro-inflammatory cytokines like TNF-alpha and IL-6 raises theoretical concern about worsening autoimmune activity, but this remains speculative without direct human data.
What time of day should I take reishi if I am on levothyroxine?
Take your levothyroxine first, ideally 30 to 60 minutes before eating anything or taking any supplement. Wait at least four hours before taking reishi. Many women find taking reishi with their evening meal or at bedtime works well with this schedule and aligns with its promoted sleep and relaxation benefits.
Can I take reishi mushroom if I have Hashimoto's?
This combination warrants more caution than hypothyroidism from other causes. Hashimoto's is an autoimmune disease, and reishi stimulates immune pathways. Whether that stimulation worsens or has no effect on the autoimmune process is unknown. Discuss this specifically with your endocrinologist before starting, rather than relying on general supplement guidance.
Is reishi mushroom safe during pregnancy if I am on Synthroid?
Reishi should be avoided in pregnancy. Animal reproduction studies have raised concerns, no adequate human pregnancy data exists, and its platelet-inhibiting and immune effects create unfavorable risk-benefit math during pregnancy. Levothyroxine itself is safe and necessary in pregnancy; your dose will likely need to increase. Skip the reishi until after delivery and, if breastfeeding, until after weaning.
Can reishi mushroom make hypothyroidism symptoms worse?
Potentially, if it shifts your thyroid hormone levels or interferes with your levothyroxine efficacy. Symptoms of worsening hypothyroidism include fatigue, weight gain, cold intolerance, constipation, and hair thinning. If you notice any of these after starting reishi, contact your prescriber and request a TSH check rather than waiting for your next scheduled visit.
Do I need to stop reishi before thyroid blood tests?
It is reasonable to take your supplement on a consistent schedule around lab days rather than stopping, so that results reflect your real-life pattern. If you do stop reishi before testing, tell your clinician so they can interpret the result in context. Stopping before a lab and restarting after can artificially mask a genuine effect on your TSH.
How long does it take to see a TSH change from a new supplement?
TSH responds to changes in thyroid hormone levels over a period of weeks, not days. The pituitary typically takes four to six weeks to register and respond to a shift in circulating T4. This is why the standard rechecking window after any medication or supplement change is six to eight weeks.

References

  1. Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 2013;3(6):439-459. PubMed. Https://pubmed.ncbi.nlm.nih.gov/26365148/
  2. Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017;376(26):2556-2565. NCBI Bookshelf. Https://www.ncbi.nlm.nih.gov/books/NBK459354/
  3. U.S. Food and Drug Administration. Levothyroxine sodium tablets information. FDA. Https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/levothyroxine-sodium-tablets-information
  4. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. PubMed. Https://pubmed.ncbi.nlm.nih.gov/31655501/
  5. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003;32(3):201-215. PubMed. Https://pubmed.ncbi.nlm.nih.gov/16169159/
  6. Yue QX, Xie FB, Guan SH, et al. Interaction of Ganoderma triterpenes with doxorubicin and inhibition of cancer cell growth. Chem Biol. 2008. PubMed. Https://pubmed.ncbi.nlm.nih.gov/15341906/
  7. Weng TC, Ou TT, Hung WC, et al. Ganoderma lucidum suppresses growth of human carcinoma cells through the inhibition of AKT-NF-kappaB signaling. Nutr Cancer. 2012. PubMed. Https://pubmed.ncbi.nlm.nih.gov/22019891/
  8. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol. 2006. PubMed. Https://pubmed.ncbi.nlm.nih.gov/18077331/
  9. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001. PubMed. Https://pubmed.ncbi.nlm.nih.gov/20508227/
  10. Wasser SP. Medicinal mushroom science: current perspectives, advances, evidences, and challenges. Biomed J. 2014;37(6):345-356. PubMed. Https://pubmed.ncbi.nlm.nih.gov/26681789/
  11. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. ACOG. Https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/06/thyroid-disease-in-pregnancy
  12. Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis and management. Treat Endocrinol. 2005. PubMed. Https://pubmed.ncbi.nlm.nih.gov/22869843/
  13. LactMed: Drugs and Lactation Database. Thyroid hormones. National Library of Medicine. Https://www.ncbi.nlm.nih.gov/books/NBK501922/
  14. Duntas LH, Chiovato L. Thyroid function in aging women. Maturitas. 2020. PubMed. Https://pubmed.ncbi.nlm.nih.gov/31993765/
  15. Munoz-Ortega MH, Avila-Blanco ME, Martinez Saldana MC, et al. Chaga mushroom (Inonotus obliquus) polyphenols and oxalate content. J Ethnopharmacol. 2014. PubMed. Https://pubmed.ncbi.nlm.nih.gov/24470100/
From$99/mo·
Take the quiz